Expert Columns by Suhasini Ravi - O'Neill : O'Neill

Opinion & Analysis

April 10, 2024

FDA v. Alliance for Hippocratic Medicine: Recapping the Supreme Court’s Oral Argument

Opinion & Analysis

October 31, 2023

What the Supreme Court’s Rulings on Chevron in Loper Bright Enterprises and Relentless Could Mean for Health Care

Opinion & Analysis

October 5, 2023

Challengers to Medicare Drug Price Negotiation Program Suffer Major Defeat

Suhasini Ravi Former Associate

The Latest

Opinion & Analysis

November 14, 2024

Progress and Pushback in Mexico’s Fight for Abortion Rights

Press Release

November 13, 2024

Katie Gottschalk to Step Down as Executive Director of the O’Neill Institute in 2025

Opinion & Analysis

November 12, 2024

Examining Overdose Inequities: 2022-23 Data